Merit Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
31,323
+132
| +0.4% | +$8.65K | 0.02% | 512 |
|
|
2025
Q1 | $2.2M | Hold |
31,191
| – | – | 0.03% | 398 |
|
|
2024
Q4 | $2.05M | Hold |
31,191
| – | – | 0.04% | 348 |
|
|
2024
Q3 | $2.2M | Sell |
31,191
-17,330
| -36% | -$1.22M | 0.05% | 260 |
|
|
2024
Q2 | $3.22M | Buy |
48,521
+17,330
| +56% | +$1.15M | 0.07% | 204 |
|
|
2024
Q1 | $2.01M | Buy |
+31,191
| New | +$2.01M | 0.05% | 263 |
|
|
2023
Q4 | – | Sell |
-31,191
| Closed | -$1.84M | – | 798 |
|
|
2023
Q3 | $1.84M | Sell |
31,191
-894
| -3% | -$52.7K | 0.06% | 231 |
|
|
2023
Q2 | $1.92M | Sell |
32,085
-14,589
| -31% | -$871K | 0.06% | 227 |
|
|
2023
Q1 | $2.73M | Buy |
46,674
+7,104
| +18% | +$415K | 0.1% | 155 |
|
|
2022
Q4 | $2.45M | Buy |
39,570
+8,544
| +28% | +$530K | 0.09% | 165 |
|
|
2022
Q3 | $1.75M | Sell |
31,026
-24,750
| -44% | -$1.4M | 0.08% | 170 |
|
|
2022
Q2 | $3.56M | Buy |
+55,776
| New | +$3.56M | 0.11% | 115 |
|